 |
|
[Alpha Biz=(Chicago) Reporter Kim Jisun] Osstem Implant Chairman Choi Kyu-ok and his two children became the second-largest shareholders as they acquired more than a 9% stake in Jusung Engineering, a KOSDAQ-listed company.
According to the Financial Supervisory Service's electronic disclosure system on the 27th, Chairman Choi announced that he acquired an 8.66% stake in Jusung Engineering. His two children, Jeong Min and In-guk, also acquired 0.21% each, with the Choi family holding a total of 9.08% stake in Jusung Engineering. The purpose of acquiring equity is 'simple investment'.
Chairman Choi bought Jusung Engineering shares between the 20th and the 26th. The acquisition unit price averaged about 21,800 won per share, with a total investment of 95.4 billion won.
Jusung Engineering's investment funds appear to be the proceeds from the sale of Osstem implants. Earlier this year, Chairman Choi sold his 9.3% stake in Osstem Implant to MBK Partners and Unison Capital Consortium, a private equity fund manager, for 274 billion won and recently completed all transactions. Choi also donated 20 billion won worth of Osstem Implant Convertible Bond (CB) call options to his two children.
Meanwhile, Osstem Implant is currently in the process of voluntary delisting. After submitting an application for delisting to the Korea Exchange on June 28, stock trading has been suspended until the date of the delisting decision.
AlphaBIZ 김지선(stockmk2020@alphabiz.co.kr)
